GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India Limited received ANDA approval for Losartan and Hydrochlorothiazide tablets30-09-2023
30-09-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity shares under the ESOP.29-09-2023
GRANULES INDIA LTD.-$ - 532482 - MSCI ESG Rating Update For GRANULES INDIA LIMITED
MSCI ESG Rating Update for Granules India Limited28-09-2023
GRANULES INDIA LTD.-$ - 532482 - Closure of Trading Window
Intimation of Trading Window Closure26-09-2023
Hot Stocks | Here's why you should bet on Granules India, Bank of Baroda for short term
For now, one needs to stay very selective with stock preferences and avoid being aggressive in the markets.25-09-2023
Granules India Share Price Live blog for 15 Sep 2023
Granules India stock price went up today, 15 Sep 2023, by 0.9 %. The stock closed at 334.5 per share. The stock is currently trading at 337.5 per share. Investors should monitor Granules India stock price closely in the coming days and weeks to see how it reacts to the news.15-09-2023
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting01-09-2023
Granules India gains on nod from Japanese, Brazilian drug regulators
The pharmaceutical raw-materials manufacturer has received approvals from the foreign drug regulators for its Jeedimetla and Bonthapally manufacturing facilities in Telangana25-08-2023
GRANULES INDIA LTD.-$ - 532482 - Granules India Limited Received Approval From Brazilian Health Regulatory Agency (ANVISA)
Granules India Limited received approval from Brazilian Health Regulatory Agency (ANVISA)24-08-2023
GRANULES INDIA LTD.-$ - 532482 - Granules India Limited Received Accreditation Certificate Of Foreign Drug Manufacturer From PMDA
Granules India Limited received Accreditation Certificate of Foreign Drug Manufacturer from PMDA24-08-2023